Upperton Pharma Solutions | Upperton Pharma Solutions

UK-based CDMO providing integrated contract development and manufacturing services. Specialising in oral, nasal, pulmonary and sterile dosage forms, the CDMO offers services that support the progression of a molecule from feasibility through formulation development, clinical trial manufacture and commercial manufacture.

Award-winning 60,000 sq.ft development and manufacturing facility in Nottingham, UK.

With over 25 years of experience, Upperton excels in rapid product introductions.

Our project delivery is unparalleled and designed to align with the values and innovation of small to mid-sized pharma companies.

We are flexible and nimble, enabling rapid decision-making, problem-solving, collaboration, and product introduction within 4–6 weeks.

With subject matter experts and leadership team oversight on every project, you can trust our delivery and expertise across all operations.

For small molecules and biologics, our clinical manufacturing process supports batch sizes from grams to kilograms.

One site advantage

60,000 sq.ft development and manufacturing facility in UK.

Development and manufacturing under one roof ensures smooth project progression. Knowledge remains within the same team, reducing handovers, maintaining clear communication, and minimising risk. By combining development, scale-up, QC and manufacturing in one location, we deliver an integrated, science-led approach that accelerates the journey from pre-clinical studies to clinic and market.

Our Manufacturing Capabilities at a Glance

• Up to 1,000,000 tableting capacity per day
• 500g–205kg blending capacity
• Up to 2,000 blister packaging units per day
• Up to 50kg tablet coating per batch
• Up to 350,000 capsule filling (powder) capacity per day
• Up to 1000kg dry granulation capacity per day
• 0.5g–10kg spray drying batch sizes (aqueous and solvent)
• 20 litres solution preparation vessel capacity with overhead mixing
• 10 state-of-the-art GMP manufacturing suites